IN10018 Clinical Trials
6 recruitingDrug
Phase 25Phase 14
Showing 1–6 of 6 trials
Recruiting
Phase 2
IN10018 With Nab-Paclitaxel and Cadonilimab for Metastatic or Recurrent Gastric-Type Cervical Adenocarcinoma: Phase 2 Trial
Cervical AdenocarcinomaGastric-type Endocervical Adenocarcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology25 enrolled2 locationsNCT06654011
Recruiting
Phase 1
A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C Mutation
NSCLC (Advanced Non-small Cell Lung Cancer)
Jemincare72 enrolled1 locationNCT06946927
Recruiting
Phase 1Phase 2
IN10018 Combination Therapy in Treatment-naïve ES-SCLC
Small Cell Lung Cancer Extensive Stage
InxMed (Shanghai) Co., Ltd.120 enrolled3 locationsNCT06030258
Recruiting
Phase 1Phase 2
IN10018+ Standard Chemotherapy (+KN046) in Subjects With Advanced Pancreatic Cancer
Pancreatic Cancer
InxMed (Shanghai) Co., Ltd.70 enrolled1 locationNCT05827796
Recruiting
Phase 2
IN10018 in Combination With Pegylated Liposomal Doxorubicin (PLD) vs. Placebo in Combination With PLD for the Treatment of Platinum-resistant Recurrent Ovarian Cancer
Ovarian Cancer Recurrent
InxMed (Shanghai) Co., Ltd.168 enrolled1 locationNCT06014528
Recruiting
Phase 1Phase 2
IN10018 Combination Therapy in Advanced EGFR Mutation-positive NSCLC
NSCLC
InxMed (Shanghai) Co., Ltd.110 enrolled1 locationNCT05994131